About Us

In 2016, he partnered with SPM Research and Development Center, obtained approval from the ICMR (Indian Council of Medical Research), and carried out the first phase of research at NARI (National AIDS Research Institute). Further, in collaboration with Dr. Arul Amuthan from Manipal University, animal studies were conducted to evaluate the side effects of this medicine, confirming that there were no adverse effects. Additionally, the first phase of cancer research using Gold Nanoparticle Size, called Cytotoxicity Analysis by MTT, was carried out at the Centre for Stem Cell and Cancer Genomics, AMI Bioscience. It has also been proven, with the help of doctors, that Gold Nanoparticle Size can be used to cure breast cancer, bladder cancer, and brain cancer.

However, due to insufficient funding for this cancer research, Mr. Shajahan urges that if central and state governments, along with pharmaceutical companies, come forward to provide support, a cancer-free world could be achieved.